Julienne E Bower1, Kate R Kuhlman2, Patricia A Ganz3, Michael R Irwin4, Catherine M Crespi5, Steve W Cole6. 1. UCLA Department of Psychology, United States; UCLA Department of Psychiatry and Biobehavioral Sciences, United States; Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, United States; Jonsson Comprehensive Cancer Center, United States. Electronic address: jbower@ucla.edu. 2. Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, United States; UC Irvine Department of Psychological Science, United States. 3. Jonsson Comprehensive Cancer Center, United States; UCLA School of Medicine, United States; UCLA Fielding School of Public Health, United States. 4. UCLA Department of Psychiatry and Biobehavioral Sciences, United States; Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, United States. 5. Jonsson Comprehensive Cancer Center, United States; UCLA Fielding School of Public Health, United States; UCLA Department of Biostatistics, United States. 6. UCLA Department of Psychiatry and Biobehavioral Sciences, United States; Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, United States; Jonsson Comprehensive Cancer Center, United States; UCLA Department of Medicine, United States.
Abstract
BACKGROUND: Childhood adversity is reliably associated with immune alterations in adulthood, including increases in inflammatory processes. However, relatively few studies have investigated these associations in clinical populations such as cancer patients who are at risk for negative immune-related health outcomes. The current study tested the hypothesis that childhood maltreatment would be associated with alterations in immune-related gene expression in monocytes from women with breast cancer. METHODS: Women (n = 86) were recruited after diagnosis with early-stage breast cancer but before onset of adjuvant therapy with radiation, chemotherapy, and/or endocrine therapy. Participants completed questionnaires to assess childhood maltreatment (Childhood Trauma Questionnaire; CTQ) and depressive symptoms (Center for Epidemiologic Studies Depression Scale; CES-D) and provided blood samples for immune assessment. CD14+ monocytes were isolated for RNA extraction and gene expression analyses. RESULTS: Based on responses to the CTQ, 28% of participants were classified as experiencing physical and/or emotional abuse or neglect and 7% as experiencing sexual abuse. Genome-wide transcriptional profiling of isolated monocytes identified 202 gene transcripts that differed in average expression level by > 25% over the range of maltreatment exposure. Bioinformatics analyses of those gene transcripts identified a significantly greater prevalence of NF-κB-binding motifs within the promoters of up-regulated vs. down-regulated genes (p = .028) in women exposed to childhood maltreatment, indicating greater inflammatory signaling. Parallel analyses of Type I interferon signaling also indicated greater prevalence of Interferon Response Factor (IRF)-related binding sites in women with a childhood maltreatment history (p = .020). Results remained significant in analyses controlling for current depression; however, NF-κB and IRF-related gene expression was higher in women with both maltreatment exposure and current depression. CONCLUSIONS: In women recently diagnosed with early-stage breast cancer, childhood maltreatment was associated with increases in the classical NF-kB-related pro-inflammatory signaling pathway and with increases in the Type I interferon system. These results suggest a broad pattern of chronic immunologic activation in breast cancer patients with a history of childhood maltreatment, particularly those who are currently experiencing clinically significant depressive symptoms. These findings have implications for the long-term health and well-being of maltreatment exposed breast cancer patients.
BACKGROUND: Childhood adversity is reliably associated with immune alterations in adulthood, including increases in inflammatory processes. However, relatively few studies have investigated these associations in clinical populations such as cancer patients who are at risk for negative immune-related health outcomes. The current study tested the hypothesis that childhood maltreatment would be associated with alterations in immune-related gene expression in monocytes from women with breast cancer. METHODS: Women (n = 86) were recruited after diagnosis with early-stage breast cancer but before onset of adjuvant therapy with radiation, chemotherapy, and/or endocrine therapy. Participants completed questionnaires to assess childhood maltreatment (Childhood Trauma Questionnaire; CTQ) and depressive symptoms (Center for Epidemiologic Studies Depression Scale; CES-D) and provided blood samples for immune assessment. CD14+ monocytes were isolated for RNA extraction and gene expression analyses. RESULTS: Based on responses to the CTQ, 28% of participants were classified as experiencing physical and/or emotional abuse or neglect and 7% as experiencing sexual abuse. Genome-wide transcriptional profiling of isolated monocytes identified 202 gene transcripts that differed in average expression level by > 25% over the range of maltreatment exposure. Bioinformatics analyses of those gene transcripts identified a significantly greater prevalence of NF-κB-binding motifs within the promoters of up-regulated vs. down-regulated genes (p = .028) in women exposed to childhood maltreatment, indicating greater inflammatory signaling. Parallel analyses of Type I interferon signaling also indicated greater prevalence of Interferon Response Factor (IRF)-related binding sites in women with a childhood maltreatment history (p = .020). Results remained significant in analyses controlling for current depression; however, NF-κB and IRF-related gene expression was higher in women with both maltreatment exposure and current depression. CONCLUSIONS: In women recently diagnosed with early-stage breast cancer, childhood maltreatment was associated with increases in the classical NF-kB-related pro-inflammatory signaling pathway and with increases in the Type I interferon system. These results suggest a broad pattern of chronic immunologic activation in breast cancer patients with a history of childhood maltreatment, particularly those who are currently experiencing clinically significant depressive symptoms. These findings have implications for the long-term health and well-being of maltreatment exposed breast cancer patients.
Authors: Daniel B McKim; Wenyuan Yin; Yufen Wang; Steve W Cole; Jonathan P Godbout; John F Sheridan Journal: Cell Rep Date: 2018-11-27 Impact factor: 9.423
Authors: Brandon L Pierce; Rachel Ballard-Barbash; Leslie Bernstein; Richard N Baumgartner; Marian L Neuhouser; Mark H Wener; Kathy B Baumgartner; Frank D Gilliland; Bess E Sorensen; Anne McTiernan; Cornelia M Ulrich Journal: J Clin Oncol Date: 2009-05-26 Impact factor: 44.544
Authors: Gregory E Miller; Michael L M Murphy; Rosemary Cashman; Roy Ma; Jeffrey Ma; Jesusa M G Arevalo; Michael S Kobor; Steve W Cole Journal: Brain Behav Immun Date: 2014-06-02 Impact factor: 7.217
Authors: Timo Heidt; Hendrik B Sager; Gabriel Courties; Partha Dutta; Yoshiko Iwamoto; Alex Zaltsman; Constantin von Zur Muhlen; Christoph Bode; Gregory L Fricchione; John Denninger; Charles P Lin; Claudio Vinegoni; Peter Libby; Filip K Swirski; Ralph Weissleder; Matthias Nahrendorf Journal: Nat Med Date: 2014-06-22 Impact factor: 53.440
Authors: Lauren V Ghazal; Steve Cole; John M Salsman; Lynne Wagner; Fenghai Duan; Ilana Gareen; Lauren Lux; Susan K Parsons; Christabel Cheung; David M Loeb; Pinki Prasad; Shira Dinner; Brad Zebrack Journal: JCO Precis Oncol Date: 2022-06
Authors: Andrew W Manigault; Kate R Kuhlman; Michael R Irwin; Steve W Cole; Patricia A Ganz; Catherine M Crespi; Julienne E Bower Journal: Brain Behav Immun Date: 2021-03-09 Impact factor: 7.217
Authors: Michelle A Chen; Angie S LeRoy; Marzieh Majd; Jonathan Y Chen; Ryan L Brown; Lisa M Christian; Christopher P Fagundes Journal: Front Psychol Date: 2021-11-26